Topol EJ - Search Results

1

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.

Aronow HD, Topol EJ, Roe MT, Houghtaling PL, Wolski KE, Lincoff AM, Harrington RA, Califf RM, Ohman EM, Kleiman NS, Keltai M, Wilcox RG, Vahanian A, Armstrong PW, Lauer MS. Aronow HD, et al. Among authors: topol ej. Lancet. 2001 Apr 7;357(9262):1063-8. doi: 10.1016/S0140-6736(00)04257-4. Lancet. 2001. PMID: 11297956

2

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.

Boersma E, Harrington RA, Moliterno DJ, White H, Théroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Boersma E, et al. Among authors: topol ej. Lancet. 2002 Jan 19;359(9302):189-98. doi: 10.1016/S0140-6736(02)07442-1. Lancet. 2002. PMID: 11812552

3

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, Mahaffey KW, Newby LK, Califf RM, Simoons ML, Topol EJ, Berger P, Lauer MS. Aviles RJ, et al. Among authors: topol ej. N Engl J Med. 2002 Jun 27;346(26):2047-52. doi: 10.1056/NEJMoa013456. N Engl J Med. 2002. PMID: 12087140 Free article.

4

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization.

Topol EJ, Lincoff AM, Kereiakes DJ, Kleiman NS, Cohen EA, Ferguson JJ, Tcheng JE, Sapp S, Califf RM. Topol EJ, et al. Am J Med. 2002 Jul;113(1):1-6. doi: 10.1016/s0002-9343(02)01145-2. Am J Med. 2002. PMID: 12106616 Clinical Trial.

5

Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.

Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA, Ommen SR, Jia G, Topol EJ; PURSUIT Investigators. Bhatt DL, et al. Among authors: topol ej. Am J Cardiol. 2003 Jul 15;92(2):136-40. doi: 10.1016/s0002-9149(03)00527-7. Am J Cardiol. 2003. PMID: 12860213

6

The rudimentary phase of personalised medicine: coronary risk scores.

Topol EJ, Lauer MS. Topol EJ, et al. Lancet. 2003 Nov 29;362(9398):1776-7. doi: 10.1016/S0140-6736(03)14941-0. Lancet. 2003. PMID: 14654312 No abstract available.

7

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ. Pilote L, et al. Among authors: topol ej. N Engl J Med. 1995 Aug 31;333(9):565-72. doi: 10.1056/NEJM199508313330907. N Engl J Med. 1995. PMID: 7623907 Free article.

8

Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Ellis SG, Lincoff AM, George BS, Kereiakes DJ, Ohman EM, Krucoff MW, Califf RM, Topol EJ. Ellis SG, et al. Among authors: topol ej. Coron Artery Dis. 1994 Jul;5(7):611-5. doi: 10.1097/00019501-199407000-00009. Coron Artery Dis. 1994. PMID: 7952423 Clinical Trial.

9

Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ. Lincoff AM, et al. Among authors: topol ej. N Engl J Med. 1999 Jul 29;341(5):319-27. doi: 10.1056/NEJM199907293410503. N Engl J Med. 1999. PMID: 10423466 Free article. Clinical Trial.

10

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.

Topol EJ, Mark DB, Lincoff AM, Cohen E, Burton J, Kleiman N, Talley D, Sapp S, Booth J, Cabot CF, Anderson KM, Califf RM. Topol EJ, et al. Lancet. 1999 Dec 11;354(9195):2019-24. doi: 10.1016/s0140-6736(99)10018-7. Lancet. 1999. PMID: 10636365 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,206 results

Search Page